Fight CRC's Statement Following a June 2021 News Story

A June 29 CBS News story highlighted a significant challenge in access to colorectal cancer screening by featuring a woman who received a positive result from an at-home, non-invasive colorectal cancer screening test (Cologuard) and needed a follow-up colonoscopy. Fortunately, she did not have colorectal cancer, but unfortunately, this patient was hit with a nearly $2,000 bill. 

While this particular patient faced this issue after completing a Cologuard test, this is an issue that can arise with any non-invasive colorectal cancer screening test. Coverage varies across insurers, but Fight Colorectal Cancer (Fight CRC) has been working at both the state and federal level to ensure that no patient faces this burdensome out-of-pocket cost in order to complete their screening process. 

“It is more important now than ever that we remove barriers and increase access to colorectal cancer screening. Unlike many cancers, colorectal cancer can be prevented if caught early, and we need to take advantage of all of the tools in our toolbox.”

Anjee Davis, President of Fight CRC

At Fight CRC, we believe that patients should work with their doctor to select the test that works best for them. Ultimately, the best test is the one that gets done so it is important that no matter how patients choose to be screened, they are able to complete the full screening process without financial barriers.

While colonoscopy is still the gold standard of colorectal cancer screening, at-home, non-invasive tests provide an important option for those at average risk who may be hesitant to get a colonoscopy. Non-invasive colorectal cancer screening tests are a key tool to help address disparities in colorectal cancer screening, and the impact of COVID-19 on colorectal cancer screening further emphasized the importance of having these options. 

It is important to talk to your doctor about which test is best for you.